ITeos Therapeutics Inc (NASDAQ:ITOS) price on current trading day, rose 3.24% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $7.49.
A look at the stock’s price movement, the level at last check in today’s session was $7.25, moving within a range at $7.265 and $7.56. The beta value (5-Year monthly) was 1.427. Turning to its 52-week performance, $18.75 and $4.80 were the 52-week high and 52-week low respectively. Overall, ITOS moved 32.95% over the past month.
ITeos Therapeutics Inc’s market cap currently stands at around $286.48 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Apr-27.
Turning to the stock’s technical picture we see that short term indicators suggest on average that ITOS is a 50% Sell. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 1 recommend ITOS as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
ITOS’s current price about 18.36% and 12.13% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 61.69, while 7-day volatility ratio is 7.40% and 8.10% in the 30-day chart. Further, ITeos Therapeutics Inc (ITOS) has a beta value of 1.39, and an average true range (ATR) of 0.46. Analysts have given the company’s stock an average 52-week price target of $17, forecast between a low of $17 and high of $17. Looking at the price targets, the low is -126.97% off recent price level in today’s trading while to achieve the yearly target high, it has to move -126.97%. Nonetheless, investors will most likely welcome a -126.97% jump to $17 which is the analysts’ median price.
If we refocus on ITeos Therapeutics Inc (NASDAQ:ITOS), historical trading data shows that trading volumes averaged 0.65 over the past 10 days and 384.58K over the past 3 months. The company’s latest data on shares outstanding shows there are 38.27 million shares.
The 13.52% of ITeos Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 78.21% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 2.02 million on 2025-04-15, giving us a short ratio of 5.74. The data shows that as of 2025-04-15 short interest in ITeos Therapeutics Inc (ITOS) stood at 952.9999999999999 of shares outstanding, with shares short rising to 1.37 million registered in 2025-03-14. Current price change has pushed the stock -2.54% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the ITOS stock continues to rise going into the next quarter.
